Screener
Carlsmed, Inc. CARL Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Carlsmed, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Carlsmed, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001794546-26-000016
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Purchase of property and equipment | (200) | (410) |
| Capitalized internal use software costs | (755) | (374) |
| Payment of initial direct costs related to operating leases | — | (126) |
| Net cash used in investing activities | (19,863) | (910) |
| Cash flows from financing activities: | ||
| Payments for deferred initial public offering costs | — | (2,648) |
| Proceeds from issuance of Series C convertible preferred stock, net of issuance costs | — | 11,919 |
| Proceeds from exercises of stock options | 472 | 183 |
Item 1. Financial Statements.
FAQ
- What is Carlsmed, Inc.'s investing cash flow?
- Carlsmed, Inc. (CARL) reported investing cash flow of -$19.66M in Q2 2026.
- How has Carlsmed, Inc.'s investing cash flow changed year-over-year?
- Carlsmed, Inc.'s investing cash flow decreased by 2825.1% year-over-year, from -$672K to -$19.66M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Carlsmed, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude